API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Nicardipine HCl Pellets are designed for controlled oral delivery of Nicardipine Hydrochloride, a calcium channel blocker used primarily in the management of hypertension and angina. These pellets leverage advanced multiparticulate technology and polymer-based coatings to ensure sustained drug release, reducing dosing frequency and improving patient compliance and therapeutic outcomes.
| Component | Function |
|---|---|
| Nicardipine HCl | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Pellets | Inert core |
| Hypromellose (HPMC) | Binder |
| Ethyl Cellulose | Sustained-release polymer |
| Eudragit RS / RL | Functional polymer |
| Triethyl Citrate (TEC) | Plasticizer |
| Talc | Anti-adherent |
| Colloidal Silicon Dioxide | Glidant and anti-adherent |
| Purified Water / Isopropyl Alcohol | Solvent used for layering and coating |
Salius Pharma offers Nicardipine HCl Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India. Our products are developed using cutting-edge pelletization and controlled-release coating techniques, ensuring consistent quality, enhanced bioavailability, and targeted release profiles.
We provide tailored strengths and pellet sizes to meet specific formulation objectives for once- or twice-daily cardiovascular therapies. With extensive experience in global exports and regulatory support, our pellets are ready for integration into finished dosage forms in both regulated and semi-regulated markets.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Nicardipine HCl Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
The pellets are coated to provide controlled release, ensuring stable blood levels of Nicardipine over time and improving patient adherence in cardiovascular treatments.
Yes. They can be directly filled into capsules or compressed into tablets, offering manufacturers flexibility in developing oral formulations.
Absolutely. Custom options include drug load, pellet size, coating type, and release profile to meet specific formulation, regulatory, or market needs.
All pellets are manufactured under GMP standards, undergo stability, dissolution, and content uniformity testing, and are shipped with complete regulatory documentation (CoA, MSDS, stability reports) for safe international export.